| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.32 | 3e-23 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.24 | 6e-15 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | 0.24 | 1e-13 |
| mRNA | TAE684 | GDSC1000 | pan-cancer | AAC | 0.36 | 5e-13 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.3 | 2e-09 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.19 | 8e-09 |
| mRNA | HG-5-88-01 | GDSC1000 | pan-cancer | AAC | 0.22 | 1e-06 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | 0.16 | 2e-06 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |